| Original language | English |
|---|---|
| Pages (from-to) | 935-936 |
| Number of pages | 2 |
| Journal | Respirology |
| Volume | 24 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2019 |
Keywords
- immunopathology
- influenza virus
- therapies
Cite this
Laghlali, G., & Tate, M. D. (2019). Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection. Respirology, 24(10), 935-936. https://doi.org/10.1111/resp.13629
@article{36161c174d934b159aef98f992bebf03,
title = "Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection",
keywords = "immunopathology, influenza virus, therapies",
author = "Gabriel Laghlali and Tate, {Michelle D.}",
year = "2019",
month = "10",
doi = "10.1111/resp.13629",
language = "English",
volume = "24",
pages = "935--936",
journal = "Respirology",
issn = "1323-7799",
publisher = "John Wiley & Sons",
number = "10",
}
Laghlali, G & Tate, MD 2019, 'Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection', Respirology, vol. 24, no. 10, pp. 935-936. https://doi.org/10.1111/resp.13629
Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection. / Laghlali, Gabriel; Tate, Michelle D.
In: Respirology, Vol. 24, No. 10, 10.2019, p. 935-936.Research output: Contribution to journal › Editorial › Other › peer-review
TY - JOUR
T1 - Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection
AU - Laghlali, Gabriel
AU - Tate, Michelle D.
PY - 2019/10
Y1 - 2019/10
KW - immunopathology
KW - influenza virus
KW - therapies
UR - http://www.scopus.com/inward/record.url?scp=85067857070&partnerID=8YFLogxK
U2 - 10.1111/resp.13629
DO - 10.1111/resp.13629
M3 - Editorial
VL - 24
SP - 935
EP - 936
JO - Respirology
JF - Respirology
SN - 1323-7799
IS - 10
ER -
Laghlali G, Tate MD. Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection. Respirology. 2019 Oct;24(10):935-936. https://doi.org/10.1111/resp.13629